ERCC2 and gastric cancer: Genetic variant in XPD Lys751Gln had been demonstrated to be associated with some cancers risk in different meta-analysis, such as esophageal cancer, gastric cancer, colorectal cancer, breast cancer, prostate cancer, lung cancer and bladder cancer [14]–[23].